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Abstract
The demand for equine cloning as a tool to preserve high genetic value is growing world-
wide; however, nuclear transfer efficiency is still very low. To address this issue, we first
evaluated the effects of time from cell fusion to activation (<1h, n = 1261; 1-2h, n = 1773; 2-
3h, n = 1647) on in vitro and in vivo development of equine embryos generated by cloning.
Then, we evaluated the effects of using different nuclear donor cell types in two successive
experiments: I) induced pluripotent stem cells (iPSCs) vs. adult fibroblasts (AF) fused to
ooplasts injected with the pluripotency-inducing genes OCT4, SOX2, MYC and KLF4, vs.
AF alone as controls; II) umbilical cord-derived mesenchymal stromal cells (UC-MSCs) vs.
fetal fibroblasts derived from an unborn cloned foetus (FF) vs. AF from the original individ-
ual. In the first experiment, both blastocyst production and pregnancy rates were higher in
the 2-3h group (11.5% and 9.5%, respectively), respect to <1h (5.2% and 2%, respectively)
and 1-2h (5.6% and 4.7%, respectively) groups (P<0.05). However, percentages of born
foals/pregnancies were similar when intervals of 2-3h (35.2%) or 1-2h (35.7%) were used.
In contrast to AF, the iPSCs did not generate any blastocyst-stage embryos. Moreover,
injection of oocytes with the pluripotency-inducing genes did not improve blastocyst pro-
duction nor pregnancy rates respect to AF controls. Finally, higher blastocyst production
was obtained using UC-MSC (15.6%) than using FF (8.9%) or AF (9.3%), (P<0.05).
Despite pregnancy rates were similar for these 3 groups (17.6%, 18.2% and 22%, respec-
tively), viable foals (two) were obtained only by using FF. In summary, optimum blastocyst
production rates can be obtained using a 2-3h interval between cell fusion and activation as
well as using UC-MSCs as nuclear donors. Moreover, FF line can improve the efficiency of
an inefficient AF line. Overall, 24 healthy foals were obtained from a total of 29 born foals.
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Introduction
Cloning is currently the only proven technique to replicate valuable animals.
In the horse, the use of cloning can be justified for the large number of extremely valuable
individuals worldwide and an increasing demand to multiply them. However, the limited num-
ber of available horse oocytes and the complexity of cloning necessitate significant technical
improvement to enhance efficiency and reduce associated costs. Most studies have reported
low blastocyst and high pregnancy loss after somatic cell nuclear transfer (SCNT), with
usually 5% of transferred embryos resulting in healthy foals [1, 2, 3, 4, 5, 6, 7]. On the other
hand, few reports have informed high blastocysts and live foals rates [8, 9, 10].
The low efficiencyand disparity of the results among groups is related to the highly complex
process that the cloning technique requires. For cloning to be successful, the differentiated state
of the donor cell needs to be reset to an embryonic state within a relatively short period of time
between embryo reconstruction and activation [11, 12]. Some reports have focusedon this step,
which has demonstrated to be beneficial to epigenetic reprogramming and normal embryo devel-
opment in different mammalian species [13, 14, 15]. However, when this interval was prolonged
embryo development was compromised [16, 17, 18], probably due to oocyte aging [19].
To improve horse cloning efficiencydifferent alternatives have been reported. Roscovitine
was used to induce G1 phase arrest in donor cells, making themmore susceptible to repro-
gramming by the oocyte cytoplasm [9, 20]. Moreover, embryo aggregation of 2, 3 or 4 zona-
free cloned embryos has been tested in order to compensate embryo-autonomous reprogram-
ming and improve developmental competence [5, 6]. Although few born foals were obtained
using both roscovitine treatment and embryo aggregation, they observed an increase in the
proportion of viable offspring born after SCNT [5, 6, 9].
In addition, the nuclear donor cell type also influences over the capacity of achieving an
undifferentiated state after nuclear reprogramming. Using foetal fibroblasts (FFs) rather than
adult fibroblasts (AFs) in the horse led to an increase in blastocyst rates [4]. In several species
pluripotent and multi-potent stem cells have been used as nuclear donors. In pigs, full-term
development of cloned embryos was significantly higher using mesenchymal stem cells
(MSCs) rather than AFs [21]. Moreover, the induced pluripotent stem cells (iPSCs) have
emerged as an alternative to SCNT through which nuclear reprogramming can be achieved in
vitro with relative high efficiency [22]. Nuclear transfer has been performed in mice using
iPSCs as nuclear donors [23], which provided relatively high efficiencyand resulted in viable
offspring. The same procedure was evaluated in pigs but failed to generate offspring [24], pre-
sumably due to the persistent expression of the reprogramming transgenes in the donor iPSCs
[24, 25]. Although horse MSCs have been isolated frommany tissues [26, 27, 28, 29, 30, 31, 32]
and horse iPSCs have been already generated [33, 34, 35], their potential as donor cells for
cloning has not been evaluated yet.
In the present study, we determined the in vitro and in vivo efficiencyof horse cloning evaluat-
ing different time periods between cell fusion and activation using AFs as nuclear donors. More-
over, we evaluated the effects of microinjecting the reprogramming genes used to generate the
iPSCs (OCT4-KLF4-MYC-SOX2) to assist the nuclear transfer procedure in the horse, and differ-
ent cell types as nuclear donors, including iPSCs, umbilical cord MSCs (UC-MSCs), FFs or AFs.
Materials and Methods
Reagents
Except when otherwise indicated, all chemicals were obtained from Sigma Chemical Company
(St. Louis, MO, USA).
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Care and Use of Research Animals
This study was carried out according to the guidelines stated in the Guide for the Care and Use
of Agricultural Animals in Agricultural Research and Teaching. The protocol was approved by
the Institutional Committee for the Care and Use of Experimental Animals of the San Martin
National University, Buenos Aires, Argentina (CICUAE-UNSAM, Permit Number: 001/16).
All procedures were performed by qualified veterinarians and all efforts were made to mini-
mize animal suffering or stress. Animal health (both mares and foetuses) were monitored once
a week.
Oocyte collection and in vitro maturation
Horse ovaries were collected from three different slaughterhouses (Lamar S.A., ruta 5 km 94,
Mercedes, Buenos Aires, Argentina, zip code: B6600; Raul Aimar S.A., ruta 36 km 597, Rio
Cuarto, Córdoba, Argentina, zip code: 5805; and E. Rios S.A., calle pública SN, Gualeguay,
Entre Rios, Argentina, zip code: 2840) and transported to the laboratory in a thermic bag at
25–29°C within 2–4 h after slaughter. Fluid from visible follicles was removed using an 18-G
needle and a 10 ml syringe. Follicles were then opened with a scalpel blade and the cumulus-
oocyte complexes (COCs)were recovered by a combination of scraping and washing the follic-
ular walls with Dulbecco´smodifiedEagleMedium (DMEM, 11885, Gibco, Grand Island, NY,
USA) supplemented with 1 mM sodium pyruvate (P2256), and 15 IU/ml heparin (H3149-
50KU). COCswere searched in Petri dishes under a stereomicroscope. For in vitromaturation,
the COCswere cultured in 100 μl microdroplets containing bicarbonate-buffered TCM-199
(31100–035; Gibco) supplemented with 10% foetal bovine serum (FBS, 10499–044; Gibco),
1 μl/ml insulin-transferrin-selenium(ITS; 51300–044, Gibco), 1 mM sodium pyruvate
(P2256), 100 mM cysteamine (M-9768), 0.1 mg/mL of follicle-stimulating hormone
(NIH-FSH-P1, Folltropin1; Bioniche, Belleville,ON, Canada) and 2% antibiotic–antimycotic
(ATB; penicillin, streptomycin and amphotericin B; 15240–096; Gibco), under mineral oil
(M8410) in 5% CO2 and humidified air at 39°C, for 22–24 h.
Removal of cumulus and zona pellucida
After in vitromaturation the oocyteswere denuded of cumulus cells by pipetting in hyaluroni-
dase solution (H4272, 1 mg⁄ml in Tyrode’s albumin lactate pyruvate medium buffered with
HEPES, TALP-H [36]) for 1 min and washed three times in TALP-H. Only those oocyteswith
a visible first polar body were used. In order to remove the zona pellucida,matured oocytes
were incubated in 1.5 mg/ml pronase (P-8811) for 3–8 min at 35°C and returned to the incuba-
tor until DNA staining for enucleation.
Microinjection of pluripotency-inducing genes
After the removal of cumulus cells, mature oocyteswere microinjectedwith the pEP4-E02s-
EM2k plasmid, which codes for the human genesOCT4, SOX2, c-MYC and K1F4 sequences
(Addgene 20923, Fig 1). The method used for DNA microinjectionwas previously described
by Vichera et al. [37] in bovine, and included liposome vesicles for higher transgenesis rates.
Briefly, 2 pl of a mixture 1/3 of plasmid/liposomes (FuGENE1 6 Transfection Reagent, Pro-
mega, Madison, WI, USA), diluted to half concentration with 10% polyvinylpyrrolidone (PVP,
99219; Irvine Scientific, Santa Ana, CA, USA) were intracytoplasmically injected using an
injection capillary of 0.7 μm in diameter (final DNA concentration of 0.5 μg/ml).
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Oocyte enucleation
Prior to enucleation, the zona-free oocyteswere incubated with 1 μg/ml Hoechst bisbenzimide
33342 (H33342) for 5 min. A closed holding pipette was used to support the oocyte during
enucleation and the metaphase plate was aspirated using a blunt pipette (14 um inner diame-
ter) under UV light, by micromanipulation with a Narishige hydraulic micromanipulator
(Medical Systems, Great Neck, NY, USA) mounted on a Nikon Eclipse Ti microscope (Nikon,
Melville, NY, USA). Enucleation was confirmed by observing the stainedmetaphase plate
inside the pipette under UV light. Enucleated oocyteswere kept in DMEM/F-12 HAM medium
(DMEM/F12, D8062) containing 10% FBS and 1% ATB for 15–30 min until fusion.
Fibroblast Culture
For fibroblast culture, small skin biopsies were obtained from 13 different horses (10 for the
first experiment, 1 for the second experiment and 2 for the third experiment). Foetal fibroblasts
were produced from the skin sample of a spontaneously aborted 5-month-old foetus cloned
from an adult fibroblast cell line used as control group. Fibroblasts were cultured in DMEM
with 10% FBS, 1% ATB and 1μl/ml of ITS in 5% CO2 in humidified air at 39°C. After 4–7 days,
fibroblasts were sub-cultured and expanded at most three times until freezing in DMEMwith
20% FBS and 10% DMSO inMr FrostyTM Freezing Container placed at -80°C for 24 h followed
by storage in liquid nitrogen. Quiescence of donor cells was induced by growth to confluence
in 0.5% FBS for 2–3 days before nuclear transfer (NT). The cells used for embryo reconstruc-
tion were harvested by trypsinization 20 min prior to NT, then washed and re-suspended in
the same medium used for culture.
Fig 1. Microinjection of non-integrative pluripotency-inducing genes in horse oocytes before enucleation. a) Plasmid construct containing the
OCT4, SOX2, MYC and KLF4 human sequences. b) Photomicrograph showing the plasmid microinjection procedure.
doi:10.1371/journal.pone.0164049.g001
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Mesenchymal umbilical cord cell culture
For UC-MSC isolation a 20 cm portion of an umbilical cord from one animal was collected
immediately after birth and placed in 500 ml of PBS with ATB. The sample was processed
within 12 h after birth. Briefly, the sample was washed with sterile PBS and dissected to sepa-
rate blood vessels. Perivascular region of the umbilical cord was then cut into 0.5 cm fragments
and placed in 50 ml conical tubes with 15 ml of 1 mg/ml type IV collagenase (17104–019, Invi-
trogen, CA, USA) at 37°C for 60 min with occasional agitation. Tubes were centrifuged for 5
min at 200 rpm to separate undigested fragments. Supernatant was placed in a new conical
tube and centrifuged for 10 min at 1000 rpm. Cells were washed once with PBS, resuspended
in DMEMwith 10% FBS and plated onto 100 mm dishes at a density of 1×104 cells/cm2. When
confluent, cells were detached from culture plates and frozen as describedpreviously.
Multilineage differentiation of MSCs
Multilineage differentiation potential of UC-MSCwas assessed using StemPro Adipogenesis
(A10070-01, Gibco), Osteogenesis (A10072-01, Gibco) or Chondrogenesis (A10071-01, Gibco)
kits, as per manufacturer instructions. After differentiation, adipogenesis induction was
assessed by Sudan Black staining. Briefly, cells were fixed with 4% paraformaldehyde solution
for 45 min at room temperature, stained with a Sudan Black saturated solution in 70% ethanol
for 5 min at room temperature and finally washed thoroughly with 70% ethanol. Osteogenesis
induction was assessed by Alzarin Red staining. Fixed cells were stained in a 2% Alzarin Red
solution (pH 4.2) for 3 min at room temperature and then washed thoroughly with distilled
water. Finally, chondrogenic induction was assessed by Alcian Blue staining. Fixed cells were
stained in a 1% Alcian Blue solution prepared in 0.1 N HCl for 30 min at room temperature
and then washed thoroughly with distilledwater. All three preparations were visualized under
light microscope. Images were acquired using a Nikon Eclipse TE2000-S inverted microscope
and the Eclipse Net software.
iPSCs culture
The iPSC-line used in this work was generated by Breton et al. [34]. This iPSC-line was gener-
ated by infecting horse fibroblasts with retrovirus containing the Moloney Murine Leukemia
Virus backbone plasmid (pMXs) with mouse cDNA sequences for Oct4, Sox2, Klf4 and c-Myc.
One vial of frozen iPSCs colonies was thawed at 37°C 24 h before NT. Cells were cultured in
DMEM supplemented with 20% FBS, 2 mM l-glutamine (G8540), 0.1mM β-mercaptoethanol
(21985023, Invitrogen), 0.1mMMEM nonessential amino acids (M7145), 1% ATB, 8 ng/ml
human basic fibroblast growth factor (bFGF, F0291) and 1,000 IU/ml human leukemia inhibi-
tory factor (LIF, L5283).
Nuclear transfer and embryo reconstruction
For embryo reconstruction, zona-free ooplasts were individually transferred to a 50 μl drop of
1mg/ml phytohemagglutinin (PHA; L8754) dissolved in TCM-199 for 2–3 s. After that, they
were quickly dropped over a single donor cell (fibroblast, MSCs or iPSCs) after which the two
structures stuck together. The couplets were placed in fusionmedium (0.3 Mmannitol, 0.1
mMMgSO4, 0.05 mMCaCl2, 1mg/ml polyvinyl alcohol) for 1 min and then moved to a fusion
chamber containing 2 ml of fusion medium at 35°C. Membrane fusion was achieved giving a
double direct current pulse of 1.2 kV/cm, each pulse for 30 μs, separated by 0.1 s. Twenty min
later, fusion was assessed and non-fused couplets were re-fused using the same parameters.
After fusion, the zona-free reconstructed embryos were placed individually in 5 μl droplets of
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DMEM/F12. After that, the reconstructed embryos were activated with 8.7 μM ionomycin
(I24222; Invitrogen, Carlsbad, CA, USA) in TALP-H for 4 min followed by individual culture
in a combination of 1 mM 6-dimethylaminopurine (6-DMAP; D2629) and 5 mg/ml cyclohexi-
mide (CHX; C7698) in 5 μl drops of DMEM/F12, for 4 h.
Embryo culture
Zona-free reconstructed embryos (ZFRE) were cultured in DMEM/F12 containing 10% FBS,
and 1% ATB, in a humidified gas mixture (5% CO2, 5% O2, 90% N2) at 39°C. Embryo aggrega-
tion of three ZFRE was performed for all the experimental groups by using the well of the well
(WOW) system. TheWOW system consists on the generation of microwells in a petri dish,
which allows individual or aggregated embryo culture that share culture media among wells.
Cleavage was assessed 72 h after activation and half of the mediumwas renewed at that time.
Blastocyst formation was evaluated after 7 and 8 days of culture. The blastocysts were trans-
ferred to synchronizedmares either at day 7 or 8.
Embryo transfer, ultrasonographic monitoring and clone birth
Non-surgical embryo transfers to recipients were performed over 3 breeding seasons (2012–
2015) in Buenos Aires, Argentina, southern hemisphere, from September to February. All
embryos were transferred to recipient mares aged 4 to 10 years old (2 blastocysts per recipient,
except when otherwise indicated). To determine the stage of the oestrus cycle each mare was
examined 6 days a week by transrectal ultrasonography (LinealMindray DP10 ultrasonogra-
pher). Ovulations were synchronized by administration of 0.15 mg Prostaglandin F2α (D-Clo-
prostenol, Emefur, Merial, Buenos Aires, Argentina) and 1500 IU hCG (Ovusyn, Syntex,
Buenos Aires, Argentina). Recipients were selected according to ultrasonographic characteris-
tics of uterus and corpus luteum, uterus tone at rectal examination and past reproductive his-
tory. Blastocysts were transported at 38°C, in 0.5 ml straw containing DMEM/F12 and
transferred within 1 h. Transcervical transfers of day-7 to -8 blastocysts were performed 6–7
days after ovulation using an embryo transfer sheath, after sanitizing the perianal area of the
mare, avoiding any pain or stress to the recipient mare. Pregnancies were diagnosed by trans-
rectal ultrasonography 7–15 days after embryo transfer. Mares that were pregnant were treated
with 1500 mg Biorelease P4 LA300 (BET Pharm LLC, Lexington, KY, USA) and monitored
once a week thereafter. Foetal monitoring consisted of observing foetal movements, heart rate
and analysing the quality of amniotic fluid in order to detect foetal suffering at the earliest pos-
sible. Between 20 to 30 days before expected parturition, the pregnant mares were transported
to an equine hospital (KAWELL, Equine Rehabilitation Centre, Solís, Argentina) to give birth.
Confirmation of Clones
To confirm that the foals born were indeed clones, 15 loci were compared in genomic DNA
between each foal and the respective donor animal (Veterinary Genetics Laboratory, University
of California, Davis, CA or Laboratorio de Genética Aplicada SociedadRural Argentina, Bue-
nos Aires, Argentina). Each locus was the same between all the cloned foals and the donor
animals.
Statistical analysis
In vitro and in vivo embryo development endpoints were compared by Chi-square or non-
parametric Fisher’s exact test using Statistix version 0.8 software. In all cases, differences were
considered significant at P<0.05.
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Results
In vitro and in vivo development of zona-free aggregated horse embryos
subjected to different time periods between cell fusion and activation
We determined the effects of 3 different time periods (between nuclear transfer and activation),
less than 1 h (<1h group), between 1 h and 2 h (1-2h group) and between 2 h and 3 h (2-3h
group), on in vitro and in vivo development of horse clones. Blastocyst development rates were
analyzed per embryo and per ZFRE. A significant improvement in blastocyst rates was
observed as fusion-to-activation time increased, with the best results obtained in the 2-3h
group: 11.5%, 5.6% and 5.2% for 2-3h, 1-2h and<1h groups, respectively (Table 1). We next
examined the in vivo effects, including pregnancy rates, number of offspring and viable off-
spring. The results in vivo agreed with those obtained in vitro, obtaining the highest pregnancy
rates (9.5%) in the 2-3h group (Table 1) and the lowest one in the<1 h group (2.0%). In this
experiment, a total of 24 foals were born, 19 from the 2-3h group, 5 from the 1-2h group and 0
from the<1 h group. Foals viability differed between groups as 2/5 of the born foals died in the
1-2h group compared to 2/19 in the 2-3h group. Those foals died during birth or immediately
after birth, mainly as consequence of umbilical abnormalities (enlargement, omphalocele,
schistosomes), observing also limb deformities and failure of passive transfer. These abnormal-
ities are commonly observed in cloned foals [6, 38, 39, 40]. By December 2015, the 20 foals
from both groups remain healthy (Fig 2A and 2B).
Table 1. Effects of different fusion-to activation times on in vitro and in vivo development of horse clones.
Blastocyst
production
Pregnancies Born foals
Fusion to
activation
times
No. of
ZFRE
No. of
embryos
(Wells)*
No. of
cleaved
(%)
No. % per
embryo
% per
ZFRE
Transferred
embryos (No.
recipients)
No. % per
transferred
embryo
% per
recipient
No.
Offspring
(%)
No. of
viable
offspring
(%)
2-3h 4941 1647 4348
(88.0)a
568 34.5a 11.5a 568 (284) 54 9.5a 19.0a 19 (35.2) 17 (31.5)
1-2h 5319 1773 4792
(90.1)b
296 16.7b 5.6b 296 (148) 14 4.7b 9.5b 5 (35.7) 3 (21.4)
<1h 3783 1261 3029
(80.1)c
196 15.5b 5.2b 196 (98) 4 2.0b 4.1b 0 -
(a, b, c) Values with different superscripts in a column are significantly different (Fisher’s exact test p<0.05).
ZFRE, zona-free reconstructed embryos.
*Embryo aggregation was performed and each well contained three ZFRE
doi:10.1371/journal.pone.0164049.t001
Fig 2. a) Cloned polo pony derived from 1-2h group in experiment 1, born on October 2013, b) Jumping horse cloned derived from 2-3h group in
experiment 1, born on November 2014, c) Thoroughbred horse cloned derived from the control group in experiment 2, born on June 2014.
doi:10.1371/journal.pone.0164049.g002
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Nuclear transfer using iPSCs and injection of pluripotency-inducing genes
We compared the effects of injecting recipient oocyteswith pluripotent gene sequences before
SCNT (AF+PGI group, for AF+pluripotent genes injection) or using iPSCs as donor cells for
SCNT (iPSCs group) on in vitro embryo development, pregnancy rates and foal births. Stan-
dard SCNT using donor adult fibroblasts (AF) was used as control. Statistical differences in
cleavage rates were observedbetweenAF+PGI and AF groups (90.5% and 85.0%, respectively)
(Table 2), with no differences in blastocyst rates (12.7% and 9.4%, respectively). However, the
embryos generated with the iPSCs had similar cleavage rates as the other two groups (87.0%)
but none was able to develop to blastocyst. Pregnancy rates did not differ statistically between
the AF+PGI and the AF groups, 3/32 (9.4%) vs. 4/43 (9.3%), respectively. The pregnancy from
the AF-PGI group resulted in the birth of one foal that died after 72 h as a consequence of
umbilical complications and systemic failure. On the other hand, both foals born in the control
group were healthy (Fig 2C).
MSCs and foetal fibroblasts as nuclear donors in zona-free horse cloning
We isolatedMSCs from the umbilical cord of a new-born foal, and we confirmed that they
could undergo lineage differentiation towards adipocytes, osteoblast or chondroblast (Fig 3),
demonstrating their pluripotent competence. In this experiment, UC-MSCs, FF and AF were
Table 2. In vitro and in vivo development of clone horse embryos reconstructed with iPSCs or after microinjection of recipient oocytes with plu-
ripotent gene sequences.
Blastocyst production Pregnancies Born foals
Groups No. of
ZFRE
No. of
embryos
(Wells)*
No. of
cleaved
(%)
No. % per
embryo
% per
ZFRE
Transferred
embryos (No.
recipients)
No. % per
transferred
embryo
% per
recipient
No.
Offspring
(%)
No. of viable
offspring
(%)
iPSCs 270 90 235
(87.0)ab
0 0a 0a - - - - - -
AF
+PGI
252 84 228
(90.5)a
32 38.1b 12.7b 32 (16) 3 9.4 18.8 1 (33.3) 0
AF 459 153 390
(85.0)b
43 28.1b 9.4b 43 (21) 4 9.3 19.0 2 (50) 2 (50)
(a, b) Values with different superscripts in a column are significantly different (Fisher’s exact test p<0.05).
ZFRE, zona-free reconstructed embryos; iPSCs, induced pluripotent stem cells; AF, adult fibroblasts; PGI, pluripotent genes injection.
* Embryo aggregation was performed and each well contained three ZFRE
doi:10.1371/journal.pone.0164049.t002
Fig 3. Multilineage differentiation of MSCs. Representative images of MSCs differentiated towards adipogenic (a), chondrogenic (b) or osteogenic (c)
lineages.
doi:10.1371/journal.pone.0164049.g003
Horse Cloning Using Different Reprogramming Times and Donor Cell Types
PLOS ONE | DOI:10.1371/journal.pone.0164049 October 12, 2016 8 / 14
used as nuclear donor cells. We obtained higher cleavage rates when UC-MSCs were used
(89.8%, 83.3% and 79.9% for UC-MSCs, FF and AF respectively) (Table 3), as well as higher
blastocyst rates (15.6%, 8.9% and 9.3% for UC-MSC, FF and AF, respectively). However, this
improvement achieved in the in vitro development was no reflected in the in vivo development.
Similar pregnancy rates were observed for all the groups [3/35 (8.6%), 2/22 (9.1%) and 2/19
(10.5%), for UC-MSC, FF and AF, respectively], though only both pregnancies derived from
the FF group resulted in 2 healthy clones.
Discussion
Although significant progress has beenmade over the past years, many aspects of horse cloning
still need to be optimized to bring about improvements in blastocyst rates and viable offspring
[38]. This progress includes the use of roscovitine for synchronization of the donor cell, utiliza-
tion of sperm extract for oocyte activation [9, 20, 41], fusion with zona-free oocytes [1, 4] and
embryo aggregation [5, 6]. In view of this, the experiments reported in this manuscript used
zona-free oocytes and embryo aggregation.
In the first experiment, we compared different time periods between cell fusion and oocyte
activation. Our results showed an improvement on in vitro and in vivo embryo development as
well as pregnancy rates when the exposure time of the somatic cell nucleus to oocyte cytoplasm
was increased up to 3 h. Similar observationswere reported for murine NT [42], whereas in
bovine longer nuclear fusion-to-activation times were beneficial in some experiments [43, 44]
but led to lower in vitro blastocyst development in others [45]. In the horse, no differences in
cleavage was reported after comparing 30 min and 2 h time windows between fusion to activa-
tion, in contrast to our findings [46]. However, Choi et al. [15] have recently demonstrated that
the use of horse oocytes immediately after reachingMII, combined with longer time periods
(5- or 8-h) from reconstruction to activation, increased developmental competence after clon-
ing. These results contrasts with those reported in the bovine, which determined that too pro-
longed exposure to arrested MII oocyte cytoplasmmay result in a high incidence of structural
abnormalities in nuclear material [11]. Our data provides a minimum interval of time required
for the donor cell to undergo appropriate embryo development. In this experiment we obtained
a total of 24 offspring, adding up to 31.5% of healthy foals per pregnancy when 2–3 h was
allowed between fusion and activation. However, future experiments are warranted in order to
strengthen these results because fewer embryos were transferred in 1–2 h and<1hs groups as
consequence of lower in vitro embryo development.
Table 3. Effect of the donor-cell differentiation state in in vitro and in vivo development of horse embryo clones.
Blastocyst production Pregnancies Born foals
Groups No. of
ZFRE
No. of
embryos
(Wells)*
No. of
cleaved
(%)
No. % per
embryo
% per
ZFRE
Transferred
embryos (No.
recipients)
No. % per
transferred
embryo
% per
recipient
No.
Offspring
(%)
No. of viable
offspring
(%)
UC-MSC 225 75 202
(89.8)a
35 46.7a 15.6a 35 (17) 3 8.6 17.6 0 -
FF 246 82 205
(83.3)b
22 26.8b 8.9b 22 (11) 2 9.1 18.2 2 (100) 2 (100)
AF 204 68 163
(79.9)b
19 27.9b 9.3ab 19 (9) 2 10.5 22.2 0 -
(a, b) Values with different superscripts in a column are significantly different (Fisher’s exact test p<0.05).
ZFRE, zona-free reconstructed embryos; UC-MSCs, mesenchymal stromal cells isolated from the umbilical cord; FF, foetal fibroblasts; AF, adult fibroblasts
* Embryo aggregation was performed and each well contained three ZFRE.
doi:10.1371/journal.pone.0164049.t003
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We also evaluated for the first time in the horse the developmental capacity of iPSCs as
nuclear donors in cloning, by comparing them with adult fibroblasts fused to ooplast that had
been injectedwith pluripotency-inducing gene sequences typically used to generate iPSCs.
Horse iPSCs have been produced by only few groups [33, 34, 47]. In this study, we used a cell
line previously generated by us [34], capable of differentiating into derivatives of the three
germ layers both in vitro and in vivo. We found that reconstructed embryos from iPSCs cleaved
normally but blocked without undergoing blastocyst formation. In another study, embryos
derived from 5 different pig iPSC lines failed to develop to term after transfer [24] presumably
because of the persistent expression of the pluripotency-inducing genes. Failure to silence the
reprogramming transgene is a common feature of iPSCs from domestic species including
bovine [48], swine [24, 49, 50] and ovine [51]. Moreover, another report in ovine obtained very
low blastocyst development rates using iPSCs as nuclear donors and found that nuclear trans-
fer blastocysts produced with fibroblasts were better reprogrammed [52]. However, cloned
mice have been generated using iPSCs [23] demonstrating the capacity of these cells to become
totipotent by nuclear transfer. It is conceivable then that the reported persistent expression of
OCT4 by our horse iPSCs [34] and by iPSCs from other species generated using the same
reprogramming system [53, 54, 55], was a main cause of cloning failure. Despite our results, we
do not rule out that iPSCs generated using non-integrating vectors could be efficient nuclear
donors and generate viable offspring in the horse. In fact, we explored this possibility by inject-
ing episomal vectors that encode for OCT4, SOX2,MYC and K1F4 in the cytoplasm of recipient
oocytes before fusion.We observed an increment of blastocyst production rates (12.7%) using
injected oocytes.Now, it is necessary to explore the molecularmechanisms by which high
expression of OCT4, SOX2,MYC and K1F4 improves reprogramming of the donor nucleus in
conventional cloning.
We also compared the capacity of UC-MSCs and FFs to develop in vitro and in vivo after
nuclear transfer. To our knowledge, there are no reports usingMSCs as nuclear donors in
horse cloning, but there are some in other species [56, 57, 58, 59, 60, 61]. One healthy clone
derived from adult MSCs in the bovine was generated before, however offspring production
rates were not better than those obtained with other somatic cell types [62], consistent with
another report [63]. In our study, significant higher blastocyst rates were obtained using
UC-MSCs than FFs or AFs but this trend was not maintained after embryo transfer, as preg-
nancy rates were similar among the 3 groups and no offspring was born using UC-MSCs. In
contrast to UC-MSCs, in vitro and in vivo embryo development using FFs as nuclear donors
were similar to using AFs. However, we obtained healthy foals only from the FF group in this
experiment. In a previous report, FFs have been used for horse cloning with good results in
terms of blastocyst rates but not after transfer into recipients [4], in contrast to our findings.
We consider that the fibroblast line used was inefficient in terms of embryo developmental
capacity and we enhance its potential by using fetal cells derived from an aborted foetus from
the inefficient line. With these results, we propose this alternative with problematic lines in
order to enhance their potential.
Overall, we obtained 29 offspring of which 24 remain healthy. The abnormalities detected
in the 5 foals that died after birth were common findings in foals derived using the cloning
[39].
Conclusions
In summary, this is to our knowledge the first report that compares different donor cell types
encompassing a wide range of developmental potentials for horse cloning, resulting in a larger
number of reconstructed embryos and born foals than in any previous study, which
Horse Cloning Using Different Reprogramming Times and Donor Cell Types
PLOS ONE | DOI:10.1371/journal.pone.0164049 October 12, 2016 10 / 14
strengthens our conclusions. Our results identified a minimal timeframe required between
fusion and activation leading to successful cloning, as no pregnancies were obtained when<1
h was allowed. Moreover, donor iPSCs did not produce any blastocyst; however, based in our
results using injection of pluripotency-inducing genes into recipient oocytes, the potential of
integration-free horse iPSCs as donor cells for cloning should be explored in the future. Finally,
UC-MSCs demonstrated high developmental potential in vitro and FFs turned out to be the
most appropriate cell source to be used as nuclear donor in terms of in vivo development to
term in horse cloning.
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